Skip to main content

Breast Cancer

Breast Cancer, FDA Approvals, In the News, Select Drug Profiles

FDA Expands Indication for Kadcyla to Include the Adjuvant Treatment of HER2-Positive Early Breast Cancer

MONALEESA-7 Sets New Standard of Care for Premenopausal Advanced Breast Cancer: Adding CDK4/6 to Endocrine Therapy Extends Survival

Phoebe Starr

Breast Cancer, FDA Approvals, In the News, Multiple Myeloma, Pediatric Cancer, Select Drug Profiles

Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News

Breast Cancer, Drug Updates, FDA Approvals

Enhertu, a Dual-Targeted Therapy, Approved for Metastatic HER2-Positive Breast Cancer

Pembrolizumab Added to First-Line Chemotherapy Improves Progression-Free Survival in Metastatic TNBC

Wayne Kuznar

No Survival Benefit with Surgery and Radiation Added to Systemic Therapy in Patients with Newly Diagnosed Stage IV Breast Cancer

Phoebe Starr

Sacituzumab Govitecan Improves Progression-Free Survival in Metastatic Triple-Negative Breast Cancer with Brain Metastases

Phoebe Starr

First-Line Pembrolizumab plus Chemotherapy Extend Progression-Free Survival in Patients with Metastatic Triple-Negative Breast Cancer

Phoebe Starr

Radiation May Be Safely Omitted in Favorable-Risk Breast Cancer Patients Aged 50 to 69 Years

1
2
3

Page 3 of 3
Results 21 - 29 of 29